Login / Signup

Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer's Disease in Clinical Practice.

Matthieu LilamandJosué CleryAgathe VrillonFrançois Mouton-LigerEmmanuel CognatSinead GaubertClaire HourregueMatthieu MartinetJulien DumurgierJacques HugonElodie Bouaziz-AmarClaire Paquet
Published in: International journal of molecular sciences (2022)
CSF Alpha-synuclein evaluation could help to early differentiate patients with DLB and AD in association with existing biomarkers.
Keyphrases
  • cerebrospinal fluid
  • clinical practice
  • mild cognitive impairment
  • cognitive decline
  • cognitive impairment